Loading company…
NeuWave Medical develops microwave ablation systems for treating soft tissue tumors.
NeuWave Medical develops the NEUWAVE™ Microwave Ablation System and probes for soft tissue ablation, including treatment of non-resectable liver tumors. Its customers include hospitals and surgical centers in the United States. Founded in 2004, the company is based in Madison, US. Its latest Series C round raised USD 25.310 mn and was led by Versant Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in